JSCO History

TOP > About JSCO > JSCO History
History of the Association

Established :  

December 5, 1963
Original Members : 662

First Academic Conference :  

December 6-7, 1963 (Kyoto)

 

Past Chairmen
*
 The office of Chairman was established in October 1997, when the Articles of Association were completely revised. The President acted as the representative of the JSCO from the time of its establishment until October 1997. See the Past Annual Meetings for details of past presidents.

 

First
Chairman 
October 1997–November 2001
Keizo SUGIMACHI,MD
(then Professor, School of Medicine, Kyushu University)

 

Second
Chairman 
November 2001–October 2005
Masaki KITAJIMA,MD
(then Professor, School of Medicine, Keio University)
  • Published the  Classification of Regional Lymph Nodes in Japan (Japanese version published October 20, 2002; English version published August 25, 2003)
  • Announced the views of the Ethics Committee on the freezing of gametes from patients due to undergo treatment for malignant cancer（October 28, 2004）
  • JSCO Declaration on the Protection of Personal Information (October 26, 2005)
  • JSCO No Smoking Declaration (November 14, 2005)
  • Held first ASCO-JSCO Symposium
  • Held UICC-JSCO Joint Fukuoka International Symposium (March 14–15, 2002, chaired by Keizo SUGIMACHI)
  • Introduced JSCO Credit Card (July 29, 2004)

 

Third
Chairman 
October 2005–October 2009
Morito MONDEN,MD
(then Member of the Board of Directors and Vice-President, Osaka University, and Professor, School of Medicine, Osaka University)
  • Established General Incorporated Association (January 5, 2009)
  • Held first Annual Meeting with fixed location (October 30–November 1, 2008, 46th Annual Meeting)
  • Formulated and implemented Clinical Oncology Research Conflict of Interest Policy (April 1, 2008)
  • Began administration of cancer Clinical Practice Guidelines (jsco-cpg.jp) (March 31, 2007)
  • Launched Data Manager certification system (July 24, 2007)
  • Participated in the establishment of the Japanese Board of Cancer Therapy (established December 16, 2006)

 

Fourth
Chairman 
October 2009−October 2011
Yoshihiko MAEHARA,MD
(Professor, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University)
  • Held Update Training Courses (twice yearly from September 2010. First two courses held under the title of “Educational Symposia.”)
  • Held lectures for the general public other than those held in conjunction with Annual Meetings (twice yearly from June 2010)
  • Launched Clinical Research Grant Program (started accepting applications from January 2011)
  • Started Cancer e-Learning training program commissioned by the Ministry of Health, Labour and Welfare (April 2011)
  • Offered support and improvement for cancer patient treatment frameworks through the establishment of the Patient Advocacy Committee (December 2009)
  • Improved framework of cooperation with overseas academic societies related to cancer treatment (ASCO, ESMO, CSCO, KACO)
  • Decided to publish an electronic journal (International Cancer Conference Journal) dedicated mainly to case reports (October 2010)

 

Fifth
Chairman 
October 2011–October 2015
Masahiko NISHIYAMA, MD
(Professor, Department of Molecular Pharmacology and Oncology, Gunma University)
  • Launched the Japan Society of Clinical Oncology (JSCO) “Certified Cancer Care Network Navigator System” (March 2015) 
  • Launched the Japan Society of Clinical Oncology (JSCO) “Certified Clinical Research Coordinator System” (April 2015) 
  • Strengthened cooperation with foreign academic societies related to cancer treatment (ASCO, ESMO and ECCO); established the Federation of Asian Clinical Oncology (FACO) with CSCO, China and KACO, Korea (February 2012)
  • Supported young researchers to attend the ASCO annual meeting and train at major institutions in the US through a ASCO/JSCO fellowship program (May 2015)
  • Started an ASCO annual meeting participation project for Patient Advocate Leadership (PAL) members (May 2014) 
  • Issued ESMO Guides for Patients, Japanese edition (August 2015)

 

Past Annual Meetings
1st
Dates： December 6–7, 1963  Location: Kyoto
President： Yasumasa AOYAGI,MD（Second Department of Surgery, Kyoto University Faculty of Medicine）
Main Program： Special Lectures
1) Two or three problems with cancer radiotherapy
2) Local administration of carcinostatic drugs, with a particular focus on continuous arterial infusion and tumor perfusion
   
2nd

Komei Nakayama


Seizo Miwa
   Dates： November 19–21, 1964  Location: Chiba
  Presidents： Komei NAKAYAMA,MD（Second Department of Surgery, School of Medicine, Chiba University）
Seizo MIWA,MD（First Department of Internal Medicine, School of Medicine, Chiba University）
  Main Program： Special Lectures
1) Malignant tumors in ophthalmology
2) Treatment of skin cancer
3) Cancer and viruses
4) Problems with the distribution of radiotherapy
and others
 

 

 
3rd
Dates： November 2–3, 1965  Location: Sendai
President： Shoichi YAMAGATA,MD（Department of Internal Medicine, Tohoku University School of Medicine）
Main Program： Symposia
1) Methods of implementation of cancer chemotherapy
2) Response evaluation criteria for cancer chemotherapy
3) Current status of cancer radiotherapy
4) Current status of surgical treatment for cancer
   
4th
Dates： December 8–9, 1966  Location: Osaka
President： Dennosuke JINNAI,MD（Second Department of Surgery, Osaka University Medical School）
Main Program： Symposia
1) Radiotherapy for malignant lymphoma (radiology)
2) Should cervical cancer be treated with surgery or radiotherapy? (gynecology)
3) Treatment of and prognosis for osteosarcoma (orthopedic surgery)
4) Treatment of end-stage cancer (surgery)
and others
   
5th
Dates： October 25–27, 1967  Location: Nagoya
President： Susumu HIBINO,MD（First Department of Internal Medicine, Nagoya University School of Medicine）
Main Program： Symposia
1) Combination use of surgery and chemotherapy with radiotherapy
2) Clinical use of hormones to suppress cancer
3) Diagnosis and treatment of pancreatic cancer
4) A consideration of cases of long-term survival as a result of anti-cancer agents
and others
   
6th
Dates： October 16–18, 1968  Location: Tokyo
President： Tamaki KAJITANI,MD（Cancer Institute Hospital, Japanese Foundation for Cancer Research）
Main Program： Symposia
1) Bone metastasis of cancer
2) Total gastrectomy for stomach cancer
3) Cancer diagnosis by angiography: Determination of tumor location, stage, and properties
4) Long-term use of anti-cancer agents
   
7th
Dates： September 4–6, 1969  Location: Niigata
President： Tetsuro SAKAI,MD（First Department of Surgery, Niigata University School of Medicine）
Main Program： Special Lectures
1) Malignant lymphoma
2) Bleomycin, a novel anti-cancer agent (fundamental and clinical aspects)
3) Epidemiological studies of cancer
4) Clinical treatment and pathology of scirrhous gastric cancer
   
8th
Dates： October 19–21, 1970  Location: Osaka
President： Shichiro ISHIKAWA,MD（National Cancer Center Hospital）
Main Program： Symposia
1) Advances in cancer diagnosis: Part 1, Part 2
2) Advances in cancer treatment: Part 1, Part 2
Panel Discussions
1) Improvements in the efficacy of carcinostatic agents
2) Liver cancer and α1-fetoglobulin
3) Specific treatment of brain tumors
   
9th
Dates： October 4–6, 1971  Location: Tokyo
President： Hirotake KAKEHI,MD（Department of Radiology, School of Medicine, Chiba University）
Main Program： Symposia
1) RI cancer diagnosis
2) Cancer treatment with a view to returning to normal life (I)
3) Cancer treatment with a view to returning to normal life (II)
4) A consideration of cancer of unknown primary
   
10th
Dates： October 19–20, 1972  Location: Tokyo
President： Michitaka KAKU,MD（Tokorozawa National Hospital）
Main Program： President’s Lecture
Treatment of cervical cancer and its future prospects
Special Lectures
1) Multipolarization of research into unknown human cancer viruses
2) A pathochemical approach to cancer metastasis mechanisms
   
11th
Dates： October 4–6, 1973  Location: Tokyo
President： Masao FUJIMORI,MD（Second Department of Surgery, Gunma University School of Medicine）
Main Program： Special Lectures
1) Biochemistry of carcinogenesis
2) Prospects for cancer chemotherapy
Symposia
1) Treatment of childhood cancer
2) Clinical treatment of endocrine-related cancers
3) Treatment of head and neck cancers that fail to respond to initial treatment
   
12th
Dates： October 7–9, 1974  Location: Kyoto
President： Masasuke MASUDA,MD（Third Department of Internal Medicine, Kyoto Prefectural University of Medicine）
Main Program： Special Lectures
1) Current status of pancreatic cancer treatment
2) Epidemiology of cancer in Japan
Symposia
1) The role of data processing in clinical oncology
2) Indications and efficacy of carcinostatic drugs
3) Early cancer diagnosis in different clinical fields
4) Long-term outcomes of extended radical surgery in different clinical fields
   
13th
Dates： October 7–9, 1975  Location: Tokyo
President： Takeshi KITAMURA,MD（Department of Otorhinolaryngology, School of Medicine, Chiba University）
Main Program： President’s Lecture
Parotid tumors
Special Lectures: Advances Series
1) Hormone receptors in cancer tissue
2) Anti-tumor activity of interferon
3) Use of high-LET radiotherapy in clinical oncology: Current status and future prospects
4) Approaches to immunotherapy for cancer
   
14th
Dates： September 30–October 2, 1976  Location: Sendai
President： Tatsuo SAITO,MD（The Research Institute for Tuberculosis, Leprosy and Cancer, Tohoku University）
Main Program： Special Lectures
1) Current status and future prospects of cancer diagnosis and treatment
2) The significance of cancer registers
3) The concept and pathology of functioning tumors
4) Redifferentiation of cancer cells
   
15th
Dates： October 6–8, 1977  Location: Fukuoka
President： Kiyoshi INOKUCHI,MD（Second Department of Surgery, Faculty of Medicine, Kyushu University）
Main Program： Special Lectures
1) Current status of clinical oncology worldwide
2) Cirrhosis of the liver and liver cancer
3) Occupational cancer
4) One approach to the search for factors in the genesis of human stomach cancer
5) Successful control of childhood solid tumor with intensive multimodal treatment
   
16th
Dates： September 6–8, 1978  Location: Nagoya
President： Tadasu IZAWA,MD（Department of Pediatrics, Mie University Faculty of Medicine）
Main Program： President’s Lecture
Immunotherapy for childhood cancer
Special Lectures
1) The search for unknown human cancer viruses
2) Current status of melanoma treatment
3) Current attitudes in the therapy of childhood lymphoma
4) Current status of the TNM classification worldwide
5) Surgical treatment for liver cancer
   
17th
Dates： September 30–Ocotber 2, 1979  Location: Tokyo
President： Heizaburo ICHIKAWA,MD（National Cancer Center Hospital）
Main Program： President’s Lecture
The effectiveness of mass screening
Special Lectures
1) The healthcare system and cancer
2) Advances in radiotherapy for cancer worldwide and the role of Japan
3) Strategies for cancer prevention from the perspective of carcinogenesis research
4) Treatment of malignant ovarian cancer
and others
   
18th
Dates： September 18–20, 1980  Location: Tokyo
President： Satoru KUSAMA,MD（First Department of Surgery, Faculty of Medicine, The University of Tokyo）
Main Program： President’s Lecture
The time science of cancer
Roundtable Discussion
Psychological aspects in the treatment of cancer patients
Special Lectures
1) Interferon and clinical oncology: its fundamental basis and future prospects
2) Statistical issues in the evaluation of response to cancer treatment
3) Concepts in the surgical management of breast cancer
   
19th
Dates： September 29–October 2, 1981  Location: Kyoto
President： Yorinori HIKASA,MD（Second Department of Surgery, Kyoto University Faculty of Medicine）
Main Program： President’s Lecture
Small efforts toward overcoming cancer
Memorial Lectures
1) The 18-year path of the Japan Society of Clinical Oncology
2) A review of stomach cancer surgery
Special Lectures
1) Cancer hormone receptors and hormone dependency
2) The adrenocorticotropin-β-lipotropin precursor gene: its structure and expression in healthy tissue and tumors
and others
   
20th
Dates： September 28–30, 1982  Location: Tokyo
President： Kazumasa MASUBUCHI,MD（Cancer Institute Hospital, Japanese Foundation for Cancer Research）
Main Program： President’s Lecture
A review of cervical cancer treatment
Special Lectures
1) Lung cancer
2) Hepatitis and hepatic cell cancer
3) The natural history of human cancer
4) A consideration of cancer prevention
5) Current status of clinical research on novel anti-cancer agents
   
21st
Dates： October 27–29, 1983  Location: Nagoya
President： Kiyoji KIMURA,MD（National Nagoya Hospital）
Main Program： President’s Lecture
Advances in cancer chemotherapy: From leukemia to solid cancer
Special Lectures
1) Cancer immunology: Monoclonal antibodies, vaccines and tumor necrosis factor
2) Strategies for the chemotherapy of solid tumor
3) Advances in the diagnosis of gastrointestinal cancer (excluding stomach cancer)
   
22nd
Dates： September 26–28, 1984  Location: Tokyo
President： Tadao NIIJIMA,MD（Department of Urology, Faculty of Medicine, The University of Tokyo）
Main Program： President’s Lecture
The history of urinary tract cancer treatment
Special Lectures
1) Basic research based on the clinical profile of bladder cancer
2) The use of NMR in cancer diagnosis
3) Multimodal immunotherapy for cancer
   
23rd
Dates： November 14–16, 1985  Location: Hiroshima
President： Takao HATTORI,MD（Department of Surgery, Research Institute for Radiation Biology and Medicine, Hiroshima University）
Main Program： President’s Lecture
The 25-year history of chemotherapy in the surgical field
Special Lectures
1) The natural history of stomach cancer from the viewpoint of the growth patterns of early-stage stomach cancer
2) Therapeutic endoscopy for gastrointestinal cancer
3) Host conditions in cancer chemotherapy
4) Hospices and treatment of cancer pain
5) Airway cancer as poisonous gas damage
and others
   
24th
Dates： October 7–9, 1986  Location: Matsue
President： Iwao MAEYAMA,MD（Department of Orthopedic Surgery, Faculty of Medicine, Tottori University）
Main Program： President’s Lecture
Diagnosis and treatment of bone tumors in Japan: History and future prospects
Special Lectures
1) Induction of differentiation of cancer cells and clinical oncology
2) Prospects for the application of immunotherapy to clinical oncology, with a focus on monoclonal antibodies and cytokines
3) Improving outcomes of cancer treatment, from the basic and clinical perspectives
4) The role of plastic surgery in clinical oncology and its progress
5) Track record and current status of nationwide registration of stomach cancer
   
25th
Dates： October 7–9, 1987  Location: Sapporo
President： Ichiro URUSHIZAKI,MD（Fourth Department of Internal Medicine, Sapporo Medical University）
Main Program： President’s Lecture
Progression from cancer immunotherapy to BRM
Special Lectures
1) The use of CSF in cancer therapy
2) Molecular mechanisms of tumor marker expression, with a focus on glutathione-S-transferase P
Japan-US Teleconference
How should patients with advanced or end-stage cancer be treated?
   
26th
Dates： September 29–October 1, 1988  Location: Niigata
President： Shoshichi TAKEUCHI,MD（Department of Obstetrics and Gynecology, Niigata University School of Medicine）
Main Program： President’s Lecture
Approaches to specific immunotherapies for cancer, seen from suggestions from the trophoblast immune evasion mechanism
Special Lectures
1) What can be hoped from clinical oncology
2) Molecular biology and clinical oncology
   
27th
Dates： October 25–27, 1989  Location: Nagoya
President： Kazuo OTA,MD（Aichi Cancer Center Research Institute）
Main Program： Special Lectures
1) Global cancer control: Strategies for developing countries
2) The trend of surgery for breast cancer in the USA
3) How to tell someone they have cancer
4) Measurement of quality of life in cancer therapy
5) Biochemical modulation of 5-fluorouracil
   
28th
Dates： October 3–5, 1990  Location: Tokyo
President： Osahiko ABE,MD（Department of Surgery, School of Medicine, Keio University）
Main Program： President’s Lecture
Phenotypical expression of breast cancer and issues in treatment
Special Lectures
1) The final common pathway of cancer
2) Treatment of bladder cancer: An integrated approach
3) New advances in cancer imaging and therapy with radiolabeled antibodies
4) Role of metalloproteinases in tissue erosion and destruction: A lesson from rheumatoid joint for tumor progression
and others
   
29th
Dates： October 16–18, 1991  Location: Osaka
President： Tetsuo TAGUCHI,MD（Department of Oncologic Surgery, Research Institute for Microbial Disease, Osaka University ）
Main Program： President’s Lecture
Prospects for biological therapies for cancer
Invited Lectures
1) Ovarian carcinoma –The challenging disease–
2) Retinol palmitate –An optimal agent for cancer prevention–
3) Immunotherapy of cancer
4) Progress in oncogene and anti-oncogene research
and others
   
30th
Dates： September 16–18, 1992  Location: Tokyo
President： Mitsumasa NISHI,MD（Cancer Institute Hospital, Japanese Foundation for Cancer Research）
Main Program： President’s Lecture
Stomach cancer treatment: History and future prospects
Special Lectures
1) Advances in clinical oncology and future prospects
2) The intersection of basic research and clinical treatment
3) History of and prospects for the diagnosis of gastrointestinal cancer
4) ATL and AIDS
   
31st
Dates： October 27–29, 1993  Location: Osaka
President： Kiichiro NODA,MD（Department of Obstetrics and Gynecology, Kinki University School of Medicine）
Main Program： President’s Lecture
Overcoming cervical cancer
Special Lectures
1) Molecular biology of carcinogenesis
2) Cancer treatments of the near future
3) Cancer and cytokines: The fundamental perspective
4) Cancer and cytokines: The clinical perspective
   
32nd
Dates： October 5–7, 1994  Location: Okayama
President： Kunzo ORITA,MD（First Department of Surgery, Okayama University Medical School）
Main Program： President’s Lecture
Cytokine (TNF + IFN) therapy from development to clinical application
Invited Lectures
1) Gene replacement strategies for therapy and prevention of lung cancer
2) Familial cancer
3) Palliative medicine
4) The management of bone and soft tissue sarcomas: the memorial hospital experience
and others
   
33rd
Dates： September 20–22, 1995  Location: Sapporo
President： Junichi UCHINO, MD（First Department of Surgery, Hokkaido University School of Medicine）
Main Program： President’s Lecture
The JSCO and hepatocellular carcinoma treatment
Special Lectures
1) The art and philosophy of clinical oncology
2) Internationalization of clinical oncology in Japan and the development of clinical oncology
3) Cancer chemotherapy and cancer cells: molecular targeting of chemotherapy
4) Epidemiology of hepatocellular carcinoma from the international perspective and its progress
and others
   
34th
Dates： November 1–3, 1996  Location: Tokyo
President： Minoru KURIHARA, MD（Department of Gastroenterology, Toyosu Hospital, Showa University）
Main Program： President’s Lecture
My history of cancer research
Special Lectures
Future prospects for cancer information networks
Invited Lectures
1) The biochemical modulation of anticancer agents: Experimental and clinical approaches
2) The control of cisplatin-induced emesis by 5-HT3 antagonists
3) Research oversight: Conducting, managing and evaluating clinical trialsa in the United States
and others
   
35th
Dates： October 7–9, 1997  Location: Kyoto
President： Osamu YOSHIDA, MD（Department of Urology, Kyoto University Faculty of Medicine）
Main Program： President’s Lecture
21st-century clinical oncology
Special Lectures
1) Diagnosis of “cancer personality” and clinical oncology
2) Skill and art in clinical oncology
3) Cancer palliative therapy and the spirit of care
Invited Lectures
1) Dreams and ideals for clinical oncology in the 21st century anticipated from progress in the molecular biology of cancer
2) The search for new knowledge in clinical oncology: Between science and welfare
3) Healing for cancer patients from the viewpoint of humanity
   
36th
Dates： October 7–9, 1998  Location: Fukuoka
Congress President： Michiaki YAKUSHIJI, MD（Department of Obstetrics and Gynecology, Kurume University School of Medicine）
Main Program： President’s Lecture
Ovarian cancer treatment: History and prospects
Special Lectures
Clinical oncology in the 21st century: The role of multimodal treatment
Invited Lectures
1) New information for overcoming resistance to anti-cancer agents
2) Angiogenesis and clinical oncology
3) Multimodal treatment: from leukemia to solid cancers
and others
   
37th
Dates： October 12–14, 1999  Location: Gifu
Congress President： Shigetoyo SAJI, MD（Second Department of Surgery, School of Medicine, Gifu University）
Theme： Toward Next Century and Next Generation
Main Program： President’s Lecture
Strategies for extending long-term survival in cases of surgical resection for cancer
Special Lectures
1) The path the JSCO should follow in the 21st century
2) 35 years of professional baseball viewed through the mask
Invited Lectures
1) Strategies against peritoneal carcinomatosis
2) Progress in the management of Wilms tumor
   
38th
Dates： October 22–24, 2000  Location: Sendai
Congress President： Ryunosuke KANAMARU, MD（Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University）
Theme： Innovative Cancer Treatment in the Future
Main Program： President’s Lecture
The current status of cancer chemotherapy and prospects for the 21st century
Special Lectures
1) Science education in the 21st century
2) Highly advanced medical treatment from the ethical and social perspectives
Invited Lectures
1) Cancer research and strategies for overcoming cancer in the 21st century, through the lens of discussion at the JSCO Council Meeting
2) Genome research and cancer chemotherapy: toward personalized treatment
and others
   
39th
Dates： November 7–9, 2001  Location: Hiroshima
Congress President： Tetsuya TOGE, MD（Department of Surgical Oncology, Research Institute for Rdiation Biology and Medicine, Aging and Cancer, Hiroshima University）
Main Program： President’s Lecture
Opening the doors of cancer: A crowd of new immunotherapies
Special Lectures
1) Advances in management of melanoma
2) Issues with and prospects for reform of the healthcare system
3) The global environment from the perspective of Egyptian civilization
4) The royal road of clinical oncology: The transformation of cancer chemotherapy
   
40th
Dates： October 16–18, 2002  Location: Tokyo
Congress President： Satoshi EBIHARA, MD（National Cancer Center Hospital East）
Main Program： President’s Lecture
What is required of surgical treatment for cancer
Special Lectures
- Talking about cancer
- Piracy past and present
Homework Lecture
New ideas in clinical oncology
   
41st
Dates： October 22–24, 2003  Location: Sapporo
Congress President： Ryuichi KUDO, MD（Department of Obstetrics and Gynecology, Sapporo Medical University）
Main Program： President’s Lecture
Individualization of cancer treatment and minimally invasive surgery
Special Lectures
1) Cancer genes from the viewpoint of virus research
2) Cancer progression and the molecular mechanism of angiogenesis and lymphangiogenesis
3) The partnership of the ASCO with the JSCO and the international oncology community
4) Translational research toward the development of molecular targeted therapeutic drugs
   
42nd
Dates： October 27–29, 2004  Location: Kyoto
Congress President： Hisakazu YAMAGISHI, MD（Department of Surgery, Kyoto Prefectural University of Medicine）
Main Program： President’s Lecture
The mind in clinical oncology
Special Lectures
The mind
Special Programs
1) Clinical oncology guidelines in different clinical fields
2) Considering the specialist oncologist system as a system for providing Japanese residents with improved cancer treatment
3) Learning from the history of medicine
4) Ethics Committee forum
5) Patients battling cancer and the doctor’s mind
   
43rd
Dates： October 25–27, 2005  Location: Nagoya
Congress President： Ryuzo OHNO, MD（Aichi Cancer Center）
Main Program： President’s Lecture
Cancer medicine in the 21st century: learning from hematopoietic tumors
Urgent invited lecture
Diagnosis and treatment of malignant pleural mesothelioma
Special Lectures
1) Application of cancer genome information to diagnosis and treatment
2) The mind of cancer patients
   
44th
Dates： October 18–20, 2006  Location: Tokyo
Congress President： Hideyuki AKAZA, MD（University of Tsukuba School of Medicine）
Main Program： President’s Lecture
A urological conception of cancer treatment
Special Program: “Clinical oncology societies, from the present to the future”
1) The JSCO: Aiming for the standardization of cancer treatment
2) The JSCO: From the present to the future
Invited Lectures
1) Multiprofessional approach for cancer treatment
2) Issues regarding the specialist oncologist system
and others
   
45th
Dates： October 24–26, 2007  Location: Kyoto
Congress President： Masahiro HIRAOKA, MD（Department of Therapeutic Radiology and Oncology, Kyoto University School of Medicine ）
Main Program： President’s Lecture
Radio-oncology: past, present, and future
Special Program: “The new shape of clinical oncology in light of the Cancer Control Act: What sort of cancer treatment do patients want?”
1) Cancer control in Japan: the significance of the Basic Plan to Promote Cancer Control Programs
2) Clinical oncology in medical training
3) Participating in the Cancer Control Promotion Council
4) The three pillars of the Cancer Control Act: radiotherapy, palliative care, and cancer registers
and others
   
46th
Dates： October 30–November 1, 2008  Location: Nagoya
Congress President： Kosei HIRAKAWA ,MD（Department of Surgical Oncology, Osaka City University Medical School）
Theme： Harmony and Network
Main Program： President’s Lecture
Clinical oncology and surgeons
Invited Lectures
1) The proper use of second opinions
2) The future of minimally invasive, individualized treatment and its prospects
3) Educational and training system of medical oncologists in USA
   
47th
Dates： October 22–24, 2009  Location: Yokohama
Congress President： Toru SUGIYAMA, MD（Department of Obstetrics & Gynecology, Iwate Medical University School of Medicine）
Theme： Perspectives of Clinical Oncology
Main Program： President’s Lecture
The challenge of treating refractory cancer
Invited Lectures
1) Advances in clinical oncology and the “semi-detached perspective”
2) Understanding the viewpoint of patients with no subjective symptoms, feel no sense of crisis, or have no intention of trying to recover
Special Lectures
1) The cancer treatment clinical oncology societies are aiming for: The view from the medical side
2) Essentials of gynecological cancer treatment: Cervical cancer surgery and Okabayashi’s radical hysterectomy
   
48th
Dates： October 28–30, 2010  Location: Kyoto International Conference Center
Congress President： Tsuneharu MIKI, MD（Department of Urology, Kyoto Prefectural University of Medicine）
Theme： Cancer Cure and Care
Main Program： President’s Lecture
Refractory testicular tumors: The battle against testicular cancer
Keynote Lecture
Curing and healing cancer
Special Lectures
1) Future prospects for the JSCO
2) Genome drug discovery: Current status and future prospects
Invited Lectures
1) Suffering from cancer three times
2) The landscape for treatment of patients with metastatic renal cell carcinoma 
   
49th
Dates： October 27–29, 2011  Location: Nagoya Congress Center
Congress President： Masahiko NISHIYAMA, MD（Research Institute for Development Therapeutics, Saitama Medical University）
Theme： Toward the goal: Finding the best way and Taking the first step
Main Program： President’s Lecture
Translational research: Toward the development of more useful cancer drug therapies
Chairman’s Lecture
The road the JSCO should take
Special Lectures
Healthcare policy from the viewpoint of the Japan Medical Association
Invited Lectures
1) Radiation exposure, healthcare, and cancer
2) Cancer pharmacogenomics: progress and obstacles toward the goal
   
50th
Dates： October 25–27, 2012  Location: Yokohama
Congress
President：		 Mitsuru SASAKO, MD（Division of Upper GI., Department of Surgery, Hyogo College of Medicine）
Theme： Leaping into the future
Main Program： Symposia
1) Types of cancer treatment, past and present
2) Current status of and future prospects for global studies
Special Programs
1) Cancer treatment in elderly patients: current status and issues for the future
2) Cancer treatment: What patients want and what is required of them
International Special Program
How should we deal with high-cost medical care?
    JSCO Prize Presentations at JSCO2012

 
51st
Dates： October 25–27, 2013  Location: Kyoto
Congress
President：		 Yutaka KOHGO,MD (Department of Medicine, Asahikawa Medical University) 
Theme： Bench to Home: Paradigm Shift in Clinical Oncology
Main Program： Congress President Lecture
From Bench to Home; my cancer research and therapy
    Excellent Presentations at JSCO2013

 
52nd 
Dates： August 28-30, 2014  Location: Yokohama
Congress
President：		 Seiichi Takenoshita,MD (Professor & Chairman Fukushima Medical University) 
Theme： Breaking new ground through perseverance
Main Program： Congress President Lecture
Review of My Strategy for Cancer Treatment Including Development of Medical-industry Cooperation as a Fukushima Model
 

  Excellent Presentations at JSCO2014

 
53rd
Dates： October 29-31, 2015; Location: Kyoto
Congress
President：		 Ikuo Konishi,MD (Professor, Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine)
Theme： We Will Live With Cancer
Main Program： Congress President Lecture
Toward Precision Medicine in Ovarian Cancer Therapeutics
 

 Excellent Presentations at JSCO2015

 
54th
Dates： October 20-22, 2016; Location: Yokohama
Congress
President：		 Takashi Nakano,MD (Professor, Department of Radiation Oncology, Gunma University Graduate School of Medicine)
Theme： Renovation of Cancer Medicine in the Mature Society
Main Program： Congress President Lecture
Further flight through lesson from the past of radiation oncology in Japan
 

 Excellent Presentations at JSCO2016

 JSCO2016 Abstracts

 
55th
Dates： October 20-22, 2017; Location: Yokohama
Congress
President：		 Masahiko Watanabe M.D., Ph.D. (Professor, Department of Surgery, Kitasato University School of Medicine)
Theme： Cancer varies. Lifestyles do too.
Main Program： Congress President Lecture
The dawn of a new cancer treatment and the future
 

 Excellent Presentations at JSCO2017

 JSCO2017 Abstracts